nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP3A4—Temozolomide—malignant glioma	0.19	1	CbGbCtD
Loratadine—Drug interaction—Carmustine—malignant glioma	0.00894	0.0422	CcSEcCtD
Loratadine—Viral infection—Temozolomide—malignant glioma	0.00887	0.0419	CcSEcCtD
Loratadine—Pollakiuria—Temozolomide—malignant glioma	0.00464	0.0219	CcSEcCtD
Loratadine—Depression—Carmustine—malignant glioma	0.00462	0.0218	CcSEcCtD
Loratadine—Depression—Temozolomide—malignant glioma	0.00447	0.0211	CcSEcCtD
Loratadine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00424	0.02	CcSEcCtD
Loratadine—Pharyngitis—Temozolomide—malignant glioma	0.00399	0.0188	CcSEcCtD
Loratadine—Tinnitus—Temozolomide—malignant glioma	0.00375	0.0177	CcSEcCtD
Loratadine—Arrhythmia—Carmustine—malignant glioma	0.00372	0.0176	CcSEcCtD
Loratadine—Alopecia—Carmustine—malignant glioma	0.00368	0.0174	CcSEcCtD
Loratadine—Immune system disorder—Temozolomide—malignant glioma	0.00363	0.0172	CcSEcCtD
Loratadine—Alopecia—Temozolomide—malignant glioma	0.00356	0.0168	CcSEcCtD
Loratadine—Dysgeusia—Temozolomide—malignant glioma	0.00343	0.0162	CcSEcCtD
Loratadine—Agitation—Carmustine—malignant glioma	0.00333	0.0157	CcSEcCtD
Loratadine—Ill-defined disorder—Temozolomide—malignant glioma	0.00325	0.0153	CcSEcCtD
Loratadine—Agitation—Temozolomide—malignant glioma	0.00322	0.0152	CcSEcCtD
Loratadine—Angioedema—Temozolomide—malignant glioma	0.0032	0.0151	CcSEcCtD
Loratadine—Malaise—Temozolomide—malignant glioma	0.00316	0.0149	CcSEcCtD
Loratadine—Hypertension—Carmustine—malignant glioma	0.00313	0.0148	CcSEcCtD
Loratadine—Palpitations—Temozolomide—malignant glioma	0.00309	0.0146	CcSEcCtD
Loratadine—Chest pain—Carmustine—malignant glioma	0.00309	0.0146	CcSEcCtD
Loratadine—Myalgia—Carmustine—malignant glioma	0.00309	0.0146	CcSEcCtD
Loratadine—Cough—Temozolomide—malignant glioma	0.00306	0.0144	CcSEcCtD
Loratadine—Hypertension—Temozolomide—malignant glioma	0.00302	0.0143	CcSEcCtD
Loratadine—Myalgia—Temozolomide—malignant glioma	0.00298	0.0141	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00296	0.014	CcSEcCtD
Loratadine—Discomfort—Temozolomide—malignant glioma	0.00295	0.0139	CcSEcCtD
Loratadine—Dry mouth—Temozolomide—malignant glioma	0.00292	0.0138	CcSEcCtD
Loratadine—Tachycardia—Carmustine—malignant glioma	0.00289	0.0136	CcSEcCtD
Loratadine—Anaphylactic shock—Temozolomide—malignant glioma	0.00286	0.0135	CcSEcCtD
Loratadine—Nervous system disorder—Temozolomide—malignant glioma	0.0028	0.0132	CcSEcCtD
Loratadine—Skin disorder—Temozolomide—malignant glioma	0.00278	0.0131	CcSEcCtD
Loratadine—Hypotension—Carmustine—malignant glioma	0.00276	0.013	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00269	0.0127	CcSEcCtD
Loratadine—Insomnia—Carmustine—malignant glioma	0.00268	0.0126	CcSEcCtD
Loratadine—Paraesthesia—Carmustine—malignant glioma	0.00266	0.0125	CcSEcCtD
Loratadine—Somnolence—Carmustine—malignant glioma	0.00263	0.0124	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.0026	0.0123	CcSEcCtD
Loratadine—Insomnia—Temozolomide—malignant glioma	0.00259	0.0122	CcSEcCtD
Loratadine—Paraesthesia—Temozolomide—malignant glioma	0.00257	0.0121	CcSEcCtD
Loratadine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00255	0.0121	CcSEcCtD
Loratadine—Somnolence—Temozolomide—malignant glioma	0.00254	0.012	CcSEcCtD
Loratadine—Constipation—Carmustine—malignant glioma	0.00253	0.0119	CcSEcCtD
Loratadine—Pain—Carmustine—malignant glioma	0.00253	0.0119	CcSEcCtD
Loratadine—Dyspepsia—Temozolomide—malignant glioma	0.00252	0.0119	CcSEcCtD
Loratadine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00247	0.0116	CcSEcCtD
Loratadine—Fatigue—Temozolomide—malignant glioma	0.00246	0.0116	CcSEcCtD
Loratadine—Pain—Temozolomide—malignant glioma	0.00244	0.0115	CcSEcCtD
Loratadine—Constipation—Temozolomide—malignant glioma	0.00244	0.0115	CcSEcCtD
Loratadine—Feeling abnormal—Carmustine—malignant glioma	0.00244	0.0115	CcSEcCtD
Loratadine—Gastrointestinal pain—Carmustine—malignant glioma	0.00242	0.0114	CcSEcCtD
Loratadine—Feeling abnormal—Temozolomide—malignant glioma	0.00236	0.0111	CcSEcCtD
Loratadine—Abdominal pain—Carmustine—malignant glioma	0.00234	0.011	CcSEcCtD
Loratadine—Body temperature increased—Carmustine—malignant glioma	0.00234	0.011	CcSEcCtD
Loratadine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00234	0.011	CcSEcCtD
Loratadine—Body temperature increased—Temozolomide—malignant glioma	0.00226	0.0107	CcSEcCtD
Loratadine—Abdominal pain—Temozolomide—malignant glioma	0.00226	0.0107	CcSEcCtD
Loratadine—Asthenia—Carmustine—malignant glioma	0.00212	0.01	CcSEcCtD
Loratadine—Asthenia—Temozolomide—malignant glioma	0.00205	0.00968	CcSEcCtD
Loratadine—Diarrhoea—Carmustine—malignant glioma	0.00202	0.00955	CcSEcCtD
Loratadine—Dizziness—Carmustine—malignant glioma	0.00196	0.00923	CcSEcCtD
Loratadine—Diarrhoea—Temozolomide—malignant glioma	0.00196	0.00923	CcSEcCtD
Loratadine—Dizziness—Temozolomide—malignant glioma	0.00189	0.00892	CcSEcCtD
Loratadine—Vomiting—Carmustine—malignant glioma	0.00188	0.00888	CcSEcCtD
Loratadine—Rash—Carmustine—malignant glioma	0.00186	0.0088	CcSEcCtD
Loratadine—Dermatitis—Carmustine—malignant glioma	0.00186	0.00879	CcSEcCtD
Loratadine—Headache—Carmustine—malignant glioma	0.00185	0.00875	CcSEcCtD
Loratadine—Vomiting—Temozolomide—malignant glioma	0.00182	0.00858	CcSEcCtD
Loratadine—Rash—Temozolomide—malignant glioma	0.0018	0.00851	CcSEcCtD
Loratadine—Dermatitis—Temozolomide—malignant glioma	0.0018	0.0085	CcSEcCtD
Loratadine—Headache—Temozolomide—malignant glioma	0.00179	0.00845	CcSEcCtD
Loratadine—Nausea—Carmustine—malignant glioma	0.00176	0.00829	CcSEcCtD
Loratadine—Nausea—Temozolomide—malignant glioma	0.0017	0.00801	CcSEcCtD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000222	0.000371	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SPHK1—malignant glioma	0.000221	0.000369	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000216	0.000362	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCR4—malignant glioma	0.000216	0.000361	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HEY1—malignant glioma	0.000216	0.000361	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP2B6—malignant glioma	0.000216	0.000361	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HIST1H3B—malignant glioma	0.00021	0.000351	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—IDH2—malignant glioma	0.000205	0.000342	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—CXCL8—malignant glioma	0.000201	0.000336	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—MMP3—malignant glioma	0.0002	0.000335	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.0002	0.000335	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—IDH2—malignant glioma	0.0002	0.000334	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—IDH1—malignant glioma	0.000197	0.00033	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000193	0.000323	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP2B6—malignant glioma	0.000192	0.000322	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—JAG2—malignant glioma	0.000192	0.00032	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—COX8A—malignant glioma	0.000191	0.000319	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—SPHK1—malignant glioma	0.000191	0.000319	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—IDH2—malignant glioma	0.000188	0.000315	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP2B6—malignant glioma	0.000188	0.000314	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP2C18—malignant glioma	0.000187	0.000313	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—IDH2—malignant glioma	0.000187	0.000312	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000184	0.000308	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.00018	0.000302	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP2B6—malignant glioma	0.000177	0.000296	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000176	0.000295	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—IDH1—malignant glioma	0.000176	0.000294	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000176	0.000294	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP2B6—malignant glioma	0.000176	0.000294	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—IDH1—malignant glioma	0.000172	0.000287	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000172	0.000287	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.00017	0.000285	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—SPHK1—malignant glioma	0.00017	0.000285	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP2C18—malignant glioma	0.000167	0.000279	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—SPHK1—malignant glioma	0.000166	0.000278	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP2C18—malignant glioma	0.000163	0.000272	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ASMT—malignant glioma	0.000162	0.000272	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—H3F3A—malignant glioma	0.000162	0.000271	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—IDH1—malignant glioma	0.000162	0.000271	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—F2—malignant glioma	0.000161	0.000269	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000161	0.000269	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CXCR3—malignant glioma	0.000161	0.000269	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—IDH1—malignant glioma	0.000161	0.000268	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000157	0.000263	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SPHK1—malignant glioma	0.000157	0.000262	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000157	0.000262	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—YWHAE—malignant glioma	0.000156	0.000261	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NTRK2—malignant glioma	0.000156	0.000261	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FLT1—malignant glioma	0.000156	0.00026	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SPHK1—malignant glioma	0.000155	0.00026	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000155	0.000259	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—DUSP6—malignant glioma	0.000155	0.000259	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000154	0.000258	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP2C18—malignant glioma	0.000153	0.000257	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—JAG1—malignant glioma	0.000153	0.000256	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—BCAN—malignant glioma	0.000153	0.000255	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOTCH3—malignant glioma	0.000152	0.000255	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP2C18—malignant glioma	0.000152	0.000254	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000151	0.000253	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTT1—malignant glioma	0.000151	0.000253	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FBXW7—malignant glioma	0.00015	0.00025	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—BDKRB2—malignant glioma	0.000147	0.000246	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—F2—malignant glioma	0.000146	0.000244	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000143	0.00024	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000143	0.00024	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTGS1—malignant glioma	0.000142	0.000237	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000141	0.000236	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—AKT2—malignant glioma	0.000141	0.000236	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CG—malignant glioma	0.00014	0.000234	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000138	0.000231	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PTPN11—malignant glioma	0.000137	0.00023	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOTCH2—malignant glioma	0.000137	0.000228	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000135	0.000226	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTT1—malignant glioma	0.000135	0.000226	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KNG1—malignant glioma	0.000134	0.000223	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTT1—malignant glioma	0.000132	0.00022	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—BCHE—malignant glioma	0.000132	0.00022	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000131	0.000219	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—SLC5A5—malignant glioma	0.00013	0.000218	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—AKT2—malignant glioma	0.000128	0.000214	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000128	0.000214	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NTRK1—malignant glioma	0.000127	0.000213	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTGS1—malignant glioma	0.000126	0.000212	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000126	0.000211	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000126	0.000211	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTT1—malignant glioma	0.000124	0.000208	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTGS1—malignant glioma	0.000123	0.000206	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—IDH2—malignant glioma	0.000123	0.000206	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTT1—malignant glioma	0.000123	0.000206	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000123	0.000206	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CD—malignant glioma	0.000123	0.000206	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000122	0.000204	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MMP3—malignant glioma	0.000118	0.000198	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000118	0.000197	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—BCHE—malignant glioma	0.000118	0.000197	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN2B—malignant glioma	0.000117	0.000196	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTGS1—malignant glioma	0.000116	0.000195	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—SLC5A5—malignant glioma	0.000116	0.000194	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2B6—malignant glioma	0.000116	0.000194	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTGS1—malignant glioma	0.000115	0.000193	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000115	0.000192	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—BCHE—malignant glioma	0.000115	0.000192	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTK2—malignant glioma	0.000114	0.000191	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—CXCL8—malignant glioma	0.000113	0.00019	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—SLC5A5—malignant glioma	0.000113	0.00019	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HES1—malignant glioma	0.000112	0.000187	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NCOR1—malignant glioma	0.000111	0.000186	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.00011	0.000184	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—RAF1—malignant glioma	0.00011	0.000184	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000109	0.000182	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—IL2—malignant glioma	0.000108	0.000181	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—BCHE—malignant glioma	0.000108	0.000181	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—BCHE—malignant glioma	0.000107	0.000179	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CB—malignant glioma	0.000107	0.000179	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SLC5A5—malignant glioma	0.000107	0.000179	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PDGFRA—malignant glioma	0.000107	0.000178	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000106	0.000178	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SLC5A5—malignant glioma	0.000106	0.000177	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—IDH1—malignant glioma	0.000106	0.000177	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTP1—malignant glioma	0.000105	0.000175	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000104	0.000175	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SPP1—malignant glioma	0.000103	0.000173	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—CXCL8—malignant glioma	0.000103	0.000172	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SPHK1—malignant glioma	0.000102	0.000171	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CAT—malignant glioma	0.000102	0.000171	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2C18—malignant glioma	0.0001	0.000168	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.0001	0.000167	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.92e-05	0.000166	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL2—malignant glioma	9.84e-05	0.000165	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TERT—malignant glioma	9.81e-05	0.000164	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NCOR1—malignant glioma	9.63e-05	0.000161	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PDGFB—malignant glioma	9.57e-05	0.00016	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGFR1—malignant glioma	9.52e-05	0.000159	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.49e-05	0.000159	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HIF1A—malignant glioma	9.38e-05	0.000157	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTP1—malignant glioma	9.36e-05	0.000156	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTP1—malignant glioma	9.13e-05	0.000153	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CAT—malignant glioma	9.1e-05	0.000152	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CAV1—malignant glioma	9.07e-05	0.000152	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KDR—malignant glioma	8.97e-05	0.00015	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CAT—malignant glioma	8.89e-05	0.000149	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.65e-05	0.000145	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—F2—malignant glioma	8.64e-05	0.000144	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FN1—malignant glioma	8.64e-05	0.000144	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTP1—malignant glioma	8.6e-05	0.000144	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NCOR1—malignant glioma	8.6e-05	0.000144	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—BAD—malignant glioma	8.53e-05	0.000143	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTP1—malignant glioma	8.53e-05	0.000143	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOTCH1—malignant glioma	8.45e-05	0.000141	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NCOR1—malignant glioma	8.39e-05	0.00014	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CAT—malignant glioma	8.37e-05	0.00014	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CAT—malignant glioma	8.3e-05	0.000139	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CD80—malignant glioma	8.28e-05	0.000138	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APC—malignant glioma	8.26e-05	0.000138	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CG—malignant glioma	8.26e-05	0.000138	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EGF—malignant glioma	8.17e-05	0.000137	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTPN11—malignant glioma	8.12e-05	0.000136	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTT1—malignant glioma	8.12e-05	0.000136	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NCOR1—malignant glioma	7.91e-05	0.000132	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CAV1—malignant glioma	7.85e-05	0.000131	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NCOR1—malignant glioma	7.84e-05	0.000131	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—BRAF—malignant glioma	7.77e-05	0.00013	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS1—malignant glioma	7.61e-05	0.000127	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT2—malignant glioma	7.56e-05	0.000126	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—EGFR—malignant glioma	7.53e-05	0.000126	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.5e-05	0.000125	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CD—malignant glioma	7.26e-05	0.000121	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	7.2e-05	0.00012	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CG—malignant glioma	7.15e-05	0.00012	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—KRAS—malignant glioma	7.11e-05	0.000119	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—BCHE—malignant glioma	7.07e-05	0.000118	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CAV1—malignant glioma	7.01e-05	0.000117	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.98e-05	0.000117	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGF2—malignant glioma	6.96e-05	0.000116	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PPARG—malignant glioma	6.9e-05	0.000115	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CAV1—malignant glioma	6.84e-05	0.000114	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.7e-05	0.000112	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	6.53e-05	0.000109	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MDM2—malignant glioma	6.51e-05	0.000109	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RAF1—malignant glioma	6.49e-05	0.000108	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CAV1—malignant glioma	6.45e-05	0.000108	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ERBB2—malignant glioma	6.42e-05	0.000107	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CAV1—malignant glioma	6.39e-05	0.000107	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CG—malignant glioma	6.38e-05	0.000107	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	6.33e-05	0.000106	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CD—malignant glioma	6.29e-05	0.000105	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CG—malignant glioma	6.23e-05	0.000104	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PPARG—malignant glioma	6.16e-05	0.000103	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.11e-05	0.000102	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CXCL8—malignant glioma	6.09e-05	0.000102	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PPARG—malignant glioma	6.01e-05	0.000101	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	5.88e-05	9.83e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.87e-05	9.82e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CASP3—malignant glioma	5.82e-05	9.74e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CG—malignant glioma	5.82e-05	9.73e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL2—malignant glioma	5.82e-05	9.73e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PPARG—malignant glioma	5.67e-05	9.48e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTP1—malignant glioma	5.63e-05	9.41e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PPARG—malignant glioma	5.62e-05	9.4e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CD—malignant glioma	5.61e-05	9.39e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MMP9—malignant glioma	5.5e-05	9.2e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CB—malignant glioma	5.48e-05	9.17e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CD—malignant glioma	5.48e-05	9.16e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CAT—malignant glioma	5.47e-05	9.16e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTEN—malignant glioma	5.47e-05	9.15e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTGS2—malignant glioma	5.43e-05	9.08e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—AKT1—malignant glioma	5.34e-05	8.93e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NCOR1—malignant glioma	5.17e-05	8.65e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CD—malignant glioma	5.16e-05	8.63e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.12e-05	8.56e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VEGFA—malignant glioma	4.94e-05	8.27e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—STAT3—malignant glioma	4.89e-05	8.18e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.89e-05	8.18e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTGS2—malignant glioma	4.85e-05	8.11e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CB—malignant glioma	4.77e-05	7.98e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTEN—malignant glioma	4.74e-05	7.92e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTGS2—malignant glioma	4.73e-05	7.91e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MYC—malignant glioma	4.55e-05	7.6e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.5e-05	7.52e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.46e-05	7.46e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTGS2—malignant glioma	4.46e-05	7.46e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EGFR—malignant glioma	4.45e-05	7.44e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTGS2—malignant glioma	4.42e-05	7.39e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTEN—malignant glioma	4.23e-05	7.07e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CAV1—malignant glioma	4.21e-05	7.05e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KRAS—malignant glioma	4.2e-05	7.03e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTEN—malignant glioma	4.13e-05	6.9e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTEN—malignant glioma	3.89e-05	6.5e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	3.86e-05	6.46e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTEN—malignant glioma	3.85e-05	6.45e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.84e-05	6.42e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TP53—malignant glioma	3.73e-05	6.25e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPARG—malignant glioma	3.71e-05	6.2e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.37e-05	5.64e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CA—malignant glioma	3.34e-05	5.59e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT1—malignant glioma	3.15e-05	5.27e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.98e-05	4.99e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.94e-05	4.92e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS2—malignant glioma	2.91e-05	4.87e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CA—malignant glioma	2.91e-05	4.87e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.74e-05	4.59e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AKT1—malignant glioma	2.73e-05	4.56e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.72e-05	4.55e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTEN—malignant glioma	2.54e-05	4.25e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AKT1—malignant glioma	2.44e-05	4.07e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AKT1—malignant glioma	2.38e-05	3.98e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AKT1—malignant glioma	2.24e-05	3.75e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AKT1—malignant glioma	2.22e-05	3.71e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.79e-05	3e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKT1—malignant glioma	1.46e-05	2.45e-05	CbGpPWpGaD
